Alogliptin attenuates cyclophosphamide-induced nephrotoxicity: a novel therapeutic approach through modulating MAP3K/JNK/SMAD3 signaling cascade

References

• Bonaventura, J., Schroeder, W.A., and Fang, S., 1972. Human erythrocyte catalase: an improved method of isolation and a reevaluation of reported properties. Archives of Biochemistry and Biophysics, 150 (2), 606–617.
   PubMed Web of Science ®Google Scholar
• Bradford, M.M., 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry, 72, 248–254.
   PubMed Web of Science ®Google Scholar
• Caglayan, C., et al., 2018. Naringin protects against cyclophosphamide-induced hepatotoxicity and nephrotoxicity through modulation of oxidative stress, inflammation, apoptosis, autophagy, and DNA damage. Environmental Science and Pollution Research International, 25 (21), 20968–20984.
   PubMed Web of Science ®Google Scholar
• Carson, F. L., and Hladik, C., 2015. Histotechnology: A Self-Instructional Text. 4 ed. Chicago: American Society for Clinical Pathology.
   Google Scholar
• Cassidy, H., et al., 2012. The role of MAPK in drug-induced kidney injury. Journal of Signal Transduction, 2012, 463617.
   PubMedGoogle Scholar
• Chang, M.W., et al., 2015. Sitagliptin protects rat kidneys from acute ischemia-reperfusion injury via upregulation of GLP-1 and GLP-1 receptors. Acta Pharmacologica Sinica, 36 (1), 119–130.
   PubMed Web of Science ®Google Scholar
• Colleoni, M., et al., 2016. Low-dose oral cyclophosphamide and methotrexate maintenance for hormone receptor-negative early breast cancer: international breast cancer study group trial 22-00. Journal of Clinical Oncology, 34 (28), 3400–3408.
   PubMed Web of Science ®Google Scholar
• Council, N. R., 1996. Guide for the Care and Use of Laboratory Animals. Washington, DC: The National Academies Press.
   Google Scholar
• Dianat, M., et al., 2016. The effects of PM10 on electrocardiogram parameters, blood pressure and oxidative stress in healthy rats: the protective effects of vanillic acid. Environmental Science and Pollution Research International, 23 (19), 19551–19560.
   PubMed Web of Science ®Google Scholar
• Ellman, G.L., 1959. Tissue sulfhydryl groups. Archives of Biochemistry and Biophysics, 82 (1), 70–77.
   PubMed Web of Science ®Google Scholar
• El-Nabarawy, N.A., et al., 2020. Effects of nitrite graded doses on hepatotoxicity and nephrotoxicity, histopathological alterations, and activation of apoptosis in adult rats. Environmental Science and Pollution Research International, 27 (12), 14019–14032.
   PubMed Web of Science ®Google Scholar
• El-Sheikh, A.A., Morsy, M.A., and Okasha, A.M., 2017. Inhibition of NF-kappaB/TNF-alpha pathway may be involved in the protective effect of resveratrol against cyclophosphamide-induced multi-organ toxicity. Immunopharmacology and Immunotoxicology, 39 (4), 180–187.
   PubMed Web of Science ®Google Scholar
• Fabregat, I., and Caballero-Diaz, D., 2018. Transforming growth factor-β-induced cell plasticity in liver fibrosis and hepatocarcinogenesis. Frontiers in Oncology, 8, 357.
   PubMed Web of Science ®Google Scholar
• Ghobadi, E., et al., 2017. The mechanisms of cyclophosphamide-induced testicular toxicity and the protective agents. Expert Opinion on Drug Metabolism & Toxicology, 13 (5), 525–536.
   PubMed Web of Science ®Google Scholar
• Gonzalez, E.J., Girard, B.M., and Vizzard, M.A., 2013. Expression and function of transforming growth factor-beta isoforms and cognate receptors in the rat urinary bladder following cyclophosphamide-induced cystitis. American Journal of Physiology-Renal Physiology, 305 (9), F1265–F1276.
   PubMed Web of Science ®Google Scholar
• Gross, J., et al., 2009. Expression of erythropoietin and angiogenic growth factors following inner ear injury of newborn rats. Prague Medical Report, 110 (4), 310–331.
   PubMedGoogle Scholar
• Grynberg, K., Ma, F.Y., and Nikolic-Paterson, D.J., 2017. The JNK signaling pathway in renal fibrosis. Frontiers in Physiology, 8, 829.
   PubMed Web of Science ®Google Scholar
• Hammouda, M.B., et al., 2020. The JNK signaling pathway in inflammatory skin disorders and cancer. Cells, 9 (4), 857.
   PubMed Web of Science ®Google Scholar
• HAS, A.L., et al., 2019. Olea europaea leaf extract up-regulates Nrf2/ARE/HO-1 signaling and attenuates cyclophosphamide-induced oxidative stress, inflammation and apoptosis in rat kidney. Biomedicine & Pharmacotherapy, 111, 676–685.
   PubMed Web of Science ®Google Scholar
• Higashijima, Y., et al., 2015. Anti-inflammatory role of DPP-4 inhibitors in a nondiabetic model of glomerular injury. American Journal of Physiology-Renal Physiology, 308 (8), F878–887.
   PubMed Web of Science ®Google Scholar
• Hwang, H.J., et al., 2015. The dipeptidyl peptidase-IV inhibitor inhibits the expression of vascular adhesion molecules and inflammatory cytokines in HUVECs via Akt- and AMPK-dependent mechanisms. Molecular and Cellular Endocrinology, 405, 25–34.
   PubMed Web of Science ®Google Scholar
• Jiang, M., et al., 2019. Combined blockade of Smad3 and JNK pathways ameliorates progressive fibrosis in folic acid nephropathy. Frontiers in Pharmacology, 10, 880.
   PubMed Web of Science ®Google Scholar
• Kabel, A.M., 2018. Zinc/alogliptin combination attenuates testicular toxicity induced by doxorubicin in rats: role of oxidative stress, apoptosis and TGF-β1/NF-κB signaling. Biomedicine and Pharmacotherapy, 97, 439–449.
   PubMed Web of Science ®Google Scholar
• Kim, S.H., et al., 2015. Diallyl disulfide prevents cyclophosphamide-induced hemorrhagic cystitis in rats through the inhibition of oxidative damage, MAPKs, and NF-kappaB pathways. Biomolecules & Therapeutics, 23 (2), 180–188.
   PubMed Web of Science ®Google Scholar
• Klein, O.R., et al., 2017. Nonmyeloablative haploidentical bone marrow transplantation with post-transplantation cyclophosphamide for pediatric and young adult patients with high-risk hematologic malignancies. Biology of Blood and Marrow Transplantation, 23 (2), 325–332.
   PubMed Web of Science ®Google Scholar
• Koike Folgueira, M.A., et al., 2009. Gene expression profile of residual breast cancer after doxorubicin and cyclophosphamide neoadjuvant chemotherapy. Oncology Reports, 22 (4), 805–813.
   PubMed Web of Science ®Google Scholar
• Lan, H.Y., and Chung, A.C., 2012. TGF-β/Smad signaling in kidney disease. Seminars in Nephrology, 32 (3), 236–243.
   PubMed Web of Science ®Google Scholar
• Laviola, L., et al., 2012. Glucagon-like peptide-1 counteracts oxidative stress-dependent apoptosis of human cardiac progenitor cells by inhibiting the activation of the c-Jun N-terminal protein kinase signaling pathway. Endocrinology, 153 (12), 5770–5781.
   PubMed Web of Science ®Google Scholar
• Lee, H.S., 2011. Mechanisms and consequences of hypertriglyceridemia and cellular lipid accumulation in chronic kidney disease and metabolic syndrome. Histology and Histopathology, 26 (12), 1599–1610.
   PubMed Web of Science ®Google Scholar
• Li, Z.L., et al., 2017. Dietary oxidized tyrosine (O-Tyr) stimulates TGF-β1-induced extracellular matrix production via the JNK/p38 signaling pathway in rat kidneys. Amino Acids, 49 (2), 241–260.
   PubMed Web of Science ®Google Scholar
• Liu, F., et al., 2012a. The cyclophosphamide metabolite, acrolein, induces cytoskeletal changes and oxidative stress in sertoli cells. Molecular Biology Reports, 39 (1), 493–500.
   PubMed Web of Science ®Google Scholar
• Liu, Q., et al., 2012b. A crosstalk between the Smad and JNK signaling in the TGF-β-induced epithelial-mesenchymal transition in rat peritoneal mesothelial cells. PLoS One, 7 (2), e32009.
   PubMed Web of Science ®Google Scholar
• Liu, Y., et al., 2019. c-Jun N-terminal kinase/transforming growth factor-β/Smad3 pathway: Is it associated with endoplasmic reticulum stress-mediated renal interstitial fibrosis?. Molecular Medicine Reports, 20 (1), 755–762.
   PubMed Web of Science ®Google Scholar
• Livak, K.J., and Schmittgen, T.D., 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods, 25 (4), 402–408.
   PubMed Web of Science ®Google Scholar
• Mansour, D.F., et al., 2017. Whey protein isolate protects against cyclophosphamide-induced acute liver and kidney damage in rats. J Appl Pharm Sci, 7 (06), 111–120.
   Google Scholar
• Marino, A.B., and Cole, S.W., 2015. Alogliptin: safety, efficacy, and clinical implications. Journal of Pharmacy Practice, 28 (1), 99–106.
   PubMedGoogle Scholar
• Marques, C., et al., 2014. Sitagliptin prevents inflammation and apoptotic cell death in the kidney of type 2 diabetic animals. Mediators of Inflammation, 2014, 538737.
   PubMed Web of Science ®Google Scholar
• Mega, C., et al., 2017. Renoprotective effects of the dipeptidyl peptidase-4 inhibitor sitagliptin: a review in type 2 diabetes. Journal of Diabetes Research, 2017, 5164292.
   PubMed Web of Science ®Google Scholar
• Meng, X.M., Nikolic-Paterson, D.J., and Lan, H.Y., 2014. Inflammatory processes in renal fibrosis. Nature Reviews Nephrology, 10 (9), 493–503.
   PubMed Web of Science ®Google Scholar
• Meng, X.M., Nikolic-Paterson, D.J., and Lan, H.Y., 2016. TGF-beta: the master regulator of fibrosis. Nature Reviews Nephrology, 12 (6), 325–338.
   PubMed Web of Science ®Google Scholar
• Moghe, A., et al., 2015. Molecular mechanisms of acrolein toxicity: relevance to human disease. Toxicological Sciences: An Official Journal of the Society of Toxicology, 143 (2), 242–255.
   PubMed Web of Science ®Google Scholar
• Moignet, A., et al., 2014. Cyclophosphamide as a first-line therapy in LGL leukemia. Leukemia, 28 (5), 1134–1136.
   PubMed Web of Science ®Google Scholar
• Muller, T.D., et al., 2019. Glucagon-like peptide 1 (GLP-1). Mol Metab, 30, 72–130.
   PubMed Web of Science ®Google Scholar
• Park, S.H., et al., 2014. Melittin inhibits TGF-beta-induced pro-fibrotic gene expression through the suppression of the TGFbetaRII-Smad, ERK1/2 and JNK-mediated signaling pathway. The American Journal of Chinese Medicine, 42 (5), 1139–1152.
   PubMed Web of Science ®Google Scholar
• Revannasiddaiah, S., et al., 2015. The results with the addition of metronomic cyclophosphamide to palliative radiotherapy for the treatment of non-small cell lung carcinoma. Annals of Translational Medicine, 3 (20), 305.
   PubMed Web of Science ®Google Scholar
• Rui, H.L., et al., 2012. JNK-dependent AP-1 activation is required for aristolochic acid-induced TGF-beta1 synthesis in human renal proximal epithelial cells. American Journal of Physiology - Renal Physiology, 302 (12), F1569–F1575.
   PubMed Web of Science ®Google Scholar
• Salama, R.M., et al., 2020. LCZ696 (sacubitril/valsartan) protects against cyclophosphamide-induced testicular toxicity in rats: role of neprilysin inhibition and lncRNA TUG1 in ameliorating apoptosis. Toxicology, 437, 152439.
   PubMed Web of Science ®Google Scholar
• Sangle, G.V., et al., 2012. Novel biological action of the dipeptidylpeptidase-IV inhibitor, sitagliptin, as a glucagon-like peptide-1 secretagogue. Endocrinology, 153 (2), 564–573.
   PubMed Web of Science ®Google Scholar
• Shi, S., et al., 2015. Interactions of DPP-4 and integrin β1 influences endothelial-to-mesenchymal transition. Kidney International, 88 (3), 479–489.
   PubMed Web of Science ®Google Scholar
• Song, J., et al., 2014. Protective effects of lipoic acid and mesna on cyclophosphamide-induced haemorrhagic cystitis in mice. Cell Biochemistry and Function, 32 (2), 125–132.
   PubMed Web of Science ®Google Scholar
• Trinder, P., 1969. Determination of blood glucose using 4-amino phenazone as oxygen acceptor. Journal of Clinical Pathology, 22 (2), 246.
   PubMed Web of Science ®Google Scholar
• Uchida, T., et al., 2017. Renoprotective effects of a dipeptidyl peptidase 4 inhibitor in a mouse model of progressive renal fibrosis. Renal Failure, 39 (1), 340–349.
   PubMed Web of Science ®Google Scholar
• Vavrinec, P., et al., 2014. Vildagliptin restores renal myogenic function and attenuates renal sclerosis independently of effects on blood glucose or proteinuria in zucker diabetic fatty rat. Current Vascular Pharmacology, 12 (6), 836–844.
   PubMed Web of Science ®Google Scholar
• Yang, B., et al., 2001. Apoptosis and caspase-3 in experimental anti-glomerular basement membrane nephritis. Journal of the American Society of Nephrology, 12 (3), 485–495.
   PubMed Web of Science ®Google Scholar
• Yimer, H., et al., 2019. Daratumumab, bortezomib, cyclophosphamide and dexamethasone in newly diagnosed and relapsed multiple myeloma: LYRA study. British Journal of Haematology, 185 (3), 492–502.
   PubMed Web of Science ®Google Scholar
• Zhang, X., et al., 2014. Dexmedetomidine inhibits tumor necrosis factor-alpha and interleukin 6 in lipopolysaccharide-stimulated astrocytes by suppression of c-Jun N-terminal kinases. Inflammation, 37 (3), 942–949.
   PubMed Web of Science ®Google Scholar
• Zhang, X., et al., 2017. Alogliptin, a dipeptidyl peptidase-4 inhibitor, alleviates atrial remodeling and improves mitochondrial function and biogenesis in diabetic rabbits. Journal of the American Heart Association, 6 (5), e005945.
   PubMed Web of Science ®Google Scholar
• Zhao, X.M., et al., 2020. Astragaloside IV synergizes with ferulic acid to alleviate hepatic fibrosis in bile duct-ligated cirrhotic rats. Digestive Diseases and Sciences. doi:https://doi.org/10.1007/s10620-019-06017-3
   Web of Science ®Google Scholar
• Zhou, L., et al., 2010. Mechanism of chronic aristolochic acid nephropathy: role of Smad3. American Journal of Physiology - Renal Physiology, 298 (4), F1006–1017.
   PubMed Web of Science ®Google Scholar